Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Jay M, Lee"'
Autor:
John Nikitas, MD, Jane Yanagawa, MD, Sandra Sacks, MD, Edward K. Hui, MD, Alan Lee, MD, Jie Deng, MD, PhD, Fereidoun Abtin, MD, Robert Suh, MD, Jay M. Lee, MD, Paul Toste, MD, Bryan M. Burt, MD, Sha’Shonda L. Revels, MD, Robert B. Cameron, MD, Drew Moghanaki, MD, MPH
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 7, Pp 100690- (2024)
Chest wall pain syndromes can emerge following local therapies for lung cancer and can adversely affect patients’ quality-of-life. This can occur after lung surgery, radiation therapy, or percutaneous image-guided thermal ablation. This review desc
Externí odkaz:
https://doaj.org/article/85c77404d66d415ea5279354dac37aad
Autor:
Nanruoyi Zhou, MD, John Deng, BS, Claire Faltermeier, MD, PhD, Terrance Peng, MD, MPH, Hanna Mandl, BS, Sha'shonda Revels, MD, MS, Paul Toste, MD, Robert B. Cameron, MD, Jay M. Lee, MD, Jane Yanagawa, MD
Publikováno v:
JTCVS Open, Vol 13, Iss , Pp 379-388 (2023)
Objective: The study objective was to determine what proportion of asymptomatic patients had resectable lung cancer detected through lung cancer screening versus incidentally. Methods: We performed a retrospective study of patients who underwent rese
Externí odkaz:
https://doaj.org/article/dce176d508b64a9c9ffa0c5b8cdd1f36
Autor:
Jay M. Lee, MD, Rongrong Wang, MPH, Ann Johnson, MMSc, Sarika Ogale, PhD, Matthew Kent, MS, Janet S. Lee, PharmD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 4, Pp 100487- (2023)
Introduction: Patients with early NSCLC (eNSCLC) who experience recurrence are associated with worse survival outcomes, but the economic burden of recurrence is not well characterized. This study evaluated the incremental health care resource utiliza
Externí odkaz:
https://doaj.org/article/91d10ed84b9f43c09032c63421450456
Autor:
Puja Shahrouki, MD, Jay M. Lee, MD, Jonathan Barclay, MD, Sarah N. Khan, MD, Scott Genshaft, MD, Fereidoun Abtin, MD, Steven M. Dubinett, MD, Aaron Lisberg, MD, Sherven Sharma, PhD, Edward B. Garon, MD, Robert Suh, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 11, Pp 100242- (2021)
Introduction: To assess the technical feasibility and safety of repeated percutaneous computed tomography (CT)–guided transthoracic biopsies and intratumoral injections of gene-modified dendritic cells in metastatic NSCLC. Methods: A total of 15 pa
Externí odkaz:
https://doaj.org/article/cf93339bf11f4025bd759e5634159336
Autor:
Jay M. Lee, MD, Anthony W. Kim, MD, Tomasz Marjanski, MD, PhD, Pierre-Emmanuel Falcoz, MD, PhD, Masahiro Tsuboi, MD, PhD, Yi-Long Wu, MD, Shawn W. Sun, PharmD, Barbara J. Gitlitz, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 10, Pp 100221- (2021)
Neoadjuvant immunotherapy may improve outcomes in patients with resectable NSCLC and is being evaluated in phase 2 and 3 studies. Nevertheless, preoperative treatment postpones resection; the potential for increased surgical complexity and greater in
Externí odkaz:
https://doaj.org/article/fba21396acdf4e6fa8789e3a680a3b71
Autor:
Veronica Dusi, Jeffrey Gornbein, Duc H. Do, Julie M. Sorg, Houman Khakpour, Yuliya Krokhaleva, Olujimi A. Ajijola, Carlos Macias, Jason S. Bradfield, Eric Buch, Osamu A. Fujimura, Noel G. Boyle, Jane Yanagawa, Jay M. Lee, Kalyanam Shivkumar, Marmar Vaseghi
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 2 (2021)
Background Cardiac sympathetic denervation (CSD) has been used as a bailout strategy for refractory ventricular tachycardia (VT). Risk of VT recurrence in patients with scar‐related monomorphic VT referred for CSD and the extent to which CSD can mo
Externí odkaz:
https://doaj.org/article/ef46c5cbb27f4b8785932442dea76cc3
Publikováno v:
Future Oncology. 19:37-47
Background: This study investigated real-world treatment patterns and overall survival (OS) in early non-small-cell lung cancer patients and the association between OS and time-to-adjuvant-treatment. Materials & methods: This retrospective study usin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bf444b11c283644dbc447105119eafb
https://doi.org/10.2217/fon-2022-0845
https://doi.org/10.2217/fon-2022-0845
Publikováno v:
The Annals of Thoracic Surgery. 114:1505-1515
Background With a 5% improvement in 5-year overall survival achieved with current neoadjuvant or adjuvant chemotherapy, new treatments for resectable non-small cell lung cancer (NSCLC) are urgently needed. The use of immune checkpoint inhibitors (ICI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb628a96e4960c62a75da3022778537f
https://doi.org/10.1016/j.athoracsur.2021.06.069
https://doi.org/10.1016/j.athoracsur.2021.06.069
Publikováno v:
Future Oncology. 18:3085-3100
Inflammation in the tumor microenvironment is a complicit and known carcinogenesis driver. Inhibition of IL-1β, one of the most abundant and influential cytokines in the tumor microenvironment, may enhance the efficacy of PD-1. In aIL-1β is a small
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f668465cd70e5ef85cbfcfb1a935935
https://doi.org/10.2217/fon-2021-1567
https://doi.org/10.2217/fon-2021-1567
Autor:
Trudy C. Wu, Annalise Stube, Carol Felix, Denise Oseguera, Tahmineh Romero, Jonathan Goldman, Edward B. Garon, Jay M. Lee, John Glaspy, Aaron E. Lisberg, Chad G. Rusthoven, D. Ross Camidge, Shankar Siva, Benjamin Solomon, Alan Lee, Stephen E. Tenn, Narek Shaverdian, Michael L. Steinberg, Ann C. Raldow, Percy Lee
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d94de890112e64a3ec5b8a8d3921ce5b
https://doi.org/10.1016/j.ijrobp.2023.03.069
https://doi.org/10.1016/j.ijrobp.2023.03.069